WEBINAR — Dec. 10, 2025 @ 11 AM ET
Integrated High-Throughput Platform for Functional Profiling of Myeloid Cells in Models of Pancreatic CancerÂ
If you’re responsible for marketing in biotech, pharma, or life sciences, this is your chance to get ahead of one of the most important shifts in digital visibility. Join us to understand the future of search, how to adapt, and how to lead.
Search is changing. Generative Engine Optimization (GEO) is emerging as the next major shift in how people discover information online, and it’s poised to reshape digital marketing across every industry, including life sciences. Traditional SEO is also changing, and marketers need to adapt to stay visible in an AI-driven search environment where large language models and generative engines surface results differently than Google’s familiar algorithms.
In this webinar, The Next Frontier: GEO and the Evolution of SEO for Life Science Marketing, we’ll explore what GEO is, why it matters, and how life science and biotech companies can prepare now. We’ll share how our team is testing and applying GEO in real campaigns, what’s working, and where the challenges remain.
Attendees will walk away with a clear understanding of how to update their marketing strategy to stay competitive in this new landscape. We’ll also look ahead at what’s still unknown, highlighting the open questions that will define the next phase of digital discovery and how forward-thinking life science brands can position themselves ahead of the curve.
Share with your network
David Villegas
Digital Marketing Manager
David Villegas (AKA Digital Dave) is a seasoned Digital Marketing Manager specializing in Google Ads and Analytics, with over a decade of experience enhancing marketing strategies within the Aerospace, Manufacturing, and Biotech industries. Known for his meticulous, data-driven approach, David empowers decision-making processes with robust analytics to drive remarkable gains in revenue, brand recognition, and conversions for his clients.
David’s expertise has consistently delivered hundreds of leads and generated thousands of dollars in sales, evidencing his ability to not only meet but exceed the marketing objectives of a diverse clientele. At Samba Scientific, David’s commitment to excellence and his relentless pursuit of optimization helps their clients enhance their digital marketing prowess and achieve substantial growth.
Dr. Sahajpal is a Laboratory Genetics and Genomics (LGG) fellow at the Greenwood Genetic Center. Before joining GGC, Dr. Sahajpal worked as a post-doctoral fellow at Augusta University, GA, US, where he was involved in pioneering optical genome mapping for investigating prenatal, postnatal, and hematological malignancies and solid tumor applications. As the world struggled with the COVID-19 pandemic, Dr. Sahajpal played a key role in establishing COVID-19 FDA-EUA approved diagnostic testing and research at Augusta University and is a key contributor of the COVID-19 host genome SV consortium.Â
Kornelia Neveling, PhD, is a scientific researcher at the Human Genetics department at the Radboud UMC in Nijmegen, the Netherlands. She earned her degree in Biology at the Heinrich-Heine-University Düsseldorf, Germany. Subsequently, she performed her PhD in Human Genetics at the Julius-Maximilians-University Würzburg, Germany, investigating the molecular causes and consequences of genetic instability syndromes, with a special interest in Fanconi anemia. In 2009, she started as a postdoc at the Dept of Human Genetics of the Radboud UMC, where she learned all about NGS. From 2011-2018 she worked at the sequencing facility and since 2018 she joined the Translational Genomics group, both at Genome Diagnostics Nijmegen. Kornelia’s main interest is in the implementation of new technologies into diagnostic routines, with long-read sequencing and long read optimal mapping being her current passion.Â
